The United Arab Emirates is making significant investments to upgrade its medical infrastructure, aiming to become a global healthcare destination. This basket provides exposure to the international US and EU-listed companies in pharmaceuticals, medtech, and digital health that supply this ambitious national project.
Published on November 12
The UAE is investing billions in new hospitals and medical facilities, creating enormous demand for the advanced equipment and services these companies provide.
As the UAE positions itself as a global healthcare destination, these international suppliers stand to benefit from sustained, long-term growth in medical infrastructure.
These aren't speculative plays - each company already has established operations, partnerships, and supply agreements with UAE healthcare authorities and major hospital groups.
The UAE is investing billions to transform its healthcare system into a world-class destination for medical tourism and advanced care. This ambitious national project relies heavily on international expertise and cutting-edge technology from global leaders in pharmaceuticals, medical devices, and digital health solutions.
This group focuses on established US and EU-listed companies that are directly supplying the UAE's healthcare modernisation. These are proven industry leaders with existing partnerships and operations in the region, offering exposure to this significant infrastructure development through the global supply chain perspective.
Each company was handpicked based on their direct involvement in the UAE's healthcare transformation. From AstraZeneca's research partnerships with Abu Dhabi to GE HealthCare's equipment supply agreements with the Ministry of Health, these stocks represent the key enablers of this national development initiative.
This basket's total market capitalisation is 1,715,711.323 (as provided) and is dominated by large-cap holdings that anchor its profile. That concentration implies generally lower volatility and closer tracking of broad-market moves.
JNJ: $466.99B
PFE: $145.04B
AZN: $275.08B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Home Depot's recent earnings beat highlights consistent consumer spending on smaller household repair and maintenance projects. This ongoing trend presents promising opportunities for various home improvement retailers and building material suppliers.
+1
Here are a few of the assets in this group. Create an account to unlock the full list.
Johnson & Johnson
JNJ
Current Price
$270.12
Johnson & Johnson's MedTech division operates a regional hub and the J&J Institute in Dubai, providing advanced surgical training and medical supplies...
Johnson & Johnson's MedTech division operates a regional hub and the J&J Institute in Dubai, providing advanced surgical training and medical supplies across the UAE.
Pfizer
PFE
Current Price
$28.39
Pfizer supports public health initiatives through its partnership with the Dubai Health Authority (DHA) and operates a major regional office in Dubai ...
Pfizer supports public health initiatives through its partnership with the Dubai Health Authority (DHA) and operates a major regional office in Dubai to supply the country.
ASTRAZENECA PLC
AZN
Current Price
$166.24
AstraZeneca partners with Abu Dhabi's G42 Healthcare on clinical research, directly supporting the UAE's vision for an advanced, innovation-driven hea...
AstraZeneca partners with Abu Dhabi's G42 Healthcare on clinical research, directly supporting the UAE's vision for an advanced, innovation-driven healthcare sector.
Join Nemo FREE today and unlock every stock
It only takes 60 seconds.
On average, analysts expect assets in this group to grow 88.49% over the next year.
8 of 11 assets in this group are rated Buy by professional analysts.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+88.49%
